Hepatobiliary Communications is an international, peer-reviewed, open-access journal dedicated to advancing the prevention, diagnosis, treatment, and translational understanding of liver and biliary diseases. Hepatobiliary Communications publishes high-quality Original Articles, Reviews, Expert Opinions/Perspectives, Short Communications/Brief Reports, and Letters to the Editor across (but not limited to) the following topics:

• Viral hepatitis

• Metabolic-associated fatty liver disease

• Alcohol-related liver disease

• Drug-induced liver injury

• Autoimmune liver diseases

• Cholestatic liver disease and biliary tract disorders

• Hepatocellular carcinoma and biliary tract malignancies

• Cirrhosis and its complications

• Acute liver failure

• Acute-on-chronic liver failure

• Liver transplantation

• Experimental and translational hepatology

• Epidemiology and population health in liver diseases

• Innovative and emerging diagnostic approaches

• Artificial intelligence and digital hepatology

Editorial Board